Bellotti M. (2003): Systemic Lupus Erythematosus Quizes. Lancet. Feb 17; 369 (9561): 587-96.
Cerner Multum W., & Wolters T. (2011): Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum. Sep 15; 61 (9): 1143-51.
De Groot F. (2013): Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus. 11:95-101.
DeCastro L., Morales W., & Wagner W. (2011): Clinical Manifestations of Systemic Lupus Erythematosus. In: Harris ED, et al, eds. Kelly's Textbook of rheumatology. 7th ed. Philadelphia, Pa: WB Saunders; p.p. 1201-24.
Fries JF. (1978): Quality of life and Pharmacoleconomics in Clinical Trials, 2nd ed, The Health Assessment Questionnaire- Status and Review. Philadelphia: Lippincott-Raven Pub, p227-237.
Giverson U. (2011): EULAR recommendations for the management of systemic lupus erythematosus. Report of a tasked of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Reum; 67(10):195-205.
Gordon K., & Smythe R. (2011): Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in cohort of 1,000 patients, 6th ed, Philadelphia, Pa: WB Saunders, p.p. 458-489.
Hakim L., Furnrohr R & Amann A. (2011): Under treatment of disease Activity in Systemic Lupus Erythematosus Patients with End stage Renal Failure is Associated with Increased All-cause Mortality. J Rheumatol. Nov; 38(11):2382-9.
Koehler F. (2011): Recommendations for adults patients with autoimmune inflammatory rheumatic disease, 2nd ed, Mosby. Boston, Toronto. London, pp. 61-70.
Krupp L., LaRocca N., Muir-Nash J., & Steinberg A. (1989): The fatigue severity scale(FSS), Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (10): 1121-1123. PubMed Abstract/Publisher full Text.
Long C. (2013): Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol. Nov-Dec; 25(6 Suppl 47): 107-13.
Lupus Foundation of America. (2012): Guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken).64(6): 797-808.
Mendoza T., & Carrasco A. (2011): The lupus band test in systemic lupus erythematosus, 2nd ed, Tronto, Saunders Comp.,p.p.100-20.
Myrthe J., Ottenhoff T., Dick U., & Rob de Jong. (2011): Prognosis, mortality and morbidity in systemic lupus erythematosus, 7th ed. Philadelphia: Lippincott Williams & Wilkins; p.p. 1333-53.
Nicol T., & Warier M. (2011): Glucocorticoid in systemic lupus erythematosus. Clin Exp Rheumatol. Sep-oct 2011; 29(5 Suppl 68):S126-9.
Przegl Lek. (2008): Socio-economic evaluation among patients with chronic illness, Philadelphia: Lippincott Williams & Wilkins; p.p. 838-850.
Rahman A & Isenberg D. (2012): Systemic lupus erythematosus. N Eng J Med; 358: 929-939.
Ritterhouse L., Crowe S., & Niewold TB. (2011): Vitamin D deficiency is associated with an increased autoimmune response in health individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. Sep 2011; 70(9): 1569-74.
Sanz Y. (2010): Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol. Feb 2010; 22(2Pt 1):181-7.
Sestak A., Furnrohr B., Harley J., & Namjou B. (2011): The genetics of systemic lupus erythematosusand implications for trargeted therapy. Ann Rheum Dis. Mar 2011; 70 Suppl l: i37-43.
Stanford Health Assessment Questionnaier. (2008): A review of its history, issues, progress & documentation. J Rheumatol, 30(1): 167-8.
Tsokos G. (2011): Systemic lupus erythematosus. N Engl J Med. Dec 2011; 365(22): 2110-21.
Wang R., & Osmond W. (2010): European League against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. 6th ed, Mosby; Louis Street, New York, pp. 322-330.
Watson R. (2011): Morbidity and mortality in systemic lupus erythematosus during a 10- year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore); 82:299-308.